United Kingdom · 
Who invested in Adaptimmune?
Adaptimmune's investors include New Enterprise Associates, OrbiMed, Wellington Management, F-Prime Capital and Foresite Capital, and 9 more on record.
2015
$3.5MGrant$104MSeries AUnited Kingdom · Series A startup
Who invested in Adaptimmune
2 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$108Mraised across 2 rounds since 2014, from 2 sources
$3.5MGrant$104MSeries A
- Latest round
- Series A, $104MSept 2014
- Step-upi
- 29.7×
- Investors
- 14
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $3.5M Mar 2014
- Biggest round
- $104M Series A · Sept 2014
- Between rounds
- 6 months from the last two
The rounds
- Sept 2014Series A$104M13 new
New Enterprise Associates
OrbiMed
Wellington Management
F-Prime Capital
Foresite Capital- Novo Holdings A/S
- Fidelity Biosciences
Rock Springs Capital
venBio Partners
QVT Financial LP
University of Oxford
Ridgeback Capital- Merlin Nexus
From a historical funding recordSEC filing: $104M sold, first sale Sept 2014
- Mar 2014
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Novo Holdings A/SGrowth equity1round
Fidelity BiosciencesInvestment firm1round
Merlin NexusPrivate equity1round
Biomedical Catalyst FundInvestment firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Adaptimmune as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Adaptimmune
How much has Adaptimmune raised?
Adaptimmune has raised $108M across 2 rounds since 2014.
When did Adaptimmune last raise?
Adaptimmune's most recent round was a Series A of $104M in Sept 2014.
What was Adaptimmune's biggest round?
Its most recent round, $104M in Sept 2014, is also its largest on record.
Who backed Adaptimmune first?
Adaptimmune's first round on record, in Mar 2014, was backed by Biomedical Catalyst Fund.
What stage is Adaptimmune at?
Adaptimmune's latest named round is a Series A, in Sept 2014.
Where is Adaptimmune based?
Adaptimmune is based in the United Kingdom.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.